Coronavirus vaccine taskforce chief Kate Bingham manages investments for drug firms
The head of the government’s vaccine taskforce has failed to publicly declare that she manages private investments in two companies involved in the race to develop coronavirus drugs. Kate Bingham is a managing partner at SV Health Investors, a venture capital firm. Two months after she was appointed by Boris Johnson, she said it was the “perfect time” to launch a fund that invested in a company researching coronavirus antibody cocktails, The Times can reveal.
The Times - November 7, 2020View the full story here: https://www.thetimes.co.uk/edition/news/coronavirus-vaccine-taskforce-chief-manages-investments-for-drug-firms-qcvxvdb6h